X4 Pharmaceuticals, Inc. · NASDAQ:XFOR
Saturn V Capital Management LP reported a 7.36% stake in X4 Pharmaceuticals, Inc. (Schedule 13G)
Event Oct 24, 2025 · Filed Feb 17, 2026
Saturn V Capital Management LP reported a 7.36% stake in X4 Pharmaceuticals, Inc., 6,433,481 shares, as a passive investor on Oct 24, 2025. Filed Feb 17, 2026 (Schedule 13G).
- Stake
- 7.36%
- Shares
- 6,433,481
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Saturn V Capital Management LP | 7.36% | 6,433,481 |
| Xiaoying Tian | 7.36% | 6,433,481 |
Source
Related
- X4 Pharmaceuticals, Inc.
- Saturn V Capital Management LP
- X4 Pharmaceuticals, Inc. shareholders
- Form 4 · Craig Adam R · Oct 19, 2026
- Schedule 13G/A · FMR LLC · Oct 7, 2026
- Form 4 · Kirske David · Oct 5, 2026
- Schedule 13G · Venrock Healthcare Capital Partners III, L.P. · Sep 21, 2026
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026